These FAQs outline key recommendations and practical takeaways from the AUA/SUFU/AUGS Genitourinary Syndrome of Menopause guideline.
|Articles|April 27, 2003
Surgical forceps available for open urologic procedures
Gyrus Medical introduces the PK System Open Forceps with an angled jawfor open urologic procedures, including prostatectomies, nephrectomies,and cystectomies. The bipolar radiofrequency-based device coagulates vesselsup to 7 mm, has minimal thermal spread, and replaces sutures and staples,the company says.
Advertisement
Advertisement
Related to this article
Sandip M. Prasad, MD, MPhil, discusses 3-year ENVISION trial data showing durable responses with mitomycin intravesical solution for recurrent LG-IR-NMIBC.
Armine K. Smith, MD, discusses sexual health counseling, sex-specific considerations, and organ-preserving approaches for patients undergoing radical cystectomy.
This approval expands the label for nogapendekin alfa inbakicept to include patients with high-grade papillary-only tumors.
Melissa Hadley Barrett discusses real-world outcomes and tolerability of intranasal vardenafil for men with persistent erectile dysfunction despite prior standard therapy.
The completion of the first procedure marks the beginning of a controlled US commercial release.
Delayed diagnosis and skipped nodal staging worsen penile cancer outcomes, according to Luis G. Medina, MD.
Butterfly Medical has also submitted a premarket approval application to the FDA.
Advertisement
Advertisement
Trending on Urology Times
1
Urocross Expander System enters US commercial use for symptomatic BPH
2
Study assesses real-world outcomes with intranasal vardenafil for ED
3
FDA approves nogapendekin alfa inbakicept plus BCG for papillary-only BCG-unresponsive NMIBC
4
Matching mCSPC treatment to the patient, not just the trial data
5